<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7532134</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">32500477</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">7532134</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">853</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1007/s13365-020-00853-0</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Demographic characteristics for NNRTI and INSTI studies</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table 1</label><caption><p>Demographic characteristics for NNRTI and INSTI studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Parameter</th><th rowspan="2">NNRTI study (efavirenz to rilpivirine)</th><th colspan="2">INSTI study (raltegravir to dolutegravir)</th></tr><tr><th>Control arm</th><th>Switch arm</th></tr></thead><tbody><tr><td>Number</td><td>10</td><td>8</td><td>12</td></tr><tr><td>Age, years median (IQR)</td><td>52 (14)</td><td>39.5 (15.5)</td><td>43 (13)</td></tr><tr><td>Male, <italic>n</italic> (%)</td><td>10 (100)</td><td>7 (87.5)</td><td>12 (100)</td></tr><tr><td>White ethnicity, <italic>n</italic> (%)</td><td>10 (100)</td><td>5 (62.5)</td><td>9 (69.2)</td></tr><tr><td>CD4+ count at study entry (cells/μL), median (IQR)</td><td>600 (256)</td><td>688 (395)</td><td>736 (237)</td></tr><tr><td>HIV RNA viral load &lt; 40 copies/mL, <italic>n</italic> (%)</td><td>10 (100)</td><td>8 (100)</td><td>12 (100)</td></tr></tbody></table><table-wrap-foot><p>Demographic characteristics for NNRTI and INSTI studies</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic characteristics for NNRTI and INSTI studies</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Parameter</th><th rowspan="2">NNRTI study (efavirenz to rilpivirine)</th><th colspan="2">INSTI study (raltegravir to dolutegravir)</th></tr><tr><th>Control arm</th><th>Switch arm</th></tr></thead><tbody><tr><td>Number</td><td>10</td><td>8</td><td>12</td></tr><tr><td>Age, years median (IQR)</td><td>52 (14)</td><td>39.5 (15.5)</td><td>43 (13)</td></tr><tr><td>Male, n (%)</td><td>10 (100)</td><td>7 (87.5)</td><td>12 (100)</td></tr><tr><td>White ethnicity, n (%)</td><td>10 (100)</td><td>5 (62.5)</td><td>9 (69.2)</td></tr><tr><td>CD4+ count at study entry (cells/μL), median (IQR)</td><td>600 (256)</td><td>688 (395)</td><td>736 (237)</td></tr><tr><td>HIV RNA viral load &lt; 40 copies/mL, n (%)</td><td>10 (100)</td><td>8 (100)</td><td>12 (100)</td></tr></tbody></table></div>Demographic characteristics for NNRTI and INSTI studies</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Changes in cognitive function by study arm (NNRTI study)</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table 2</label><caption><p>Changes in cognitive function by study arm (NNRTI study)</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th>Baseline</th><th>6 months</th><th>Changes at 6 months from baseline</th><th><italic>p</italic> value</th></tr><tr><th>Cognitive test</th><th>Cognitive domain</th><th>Outcome measure</th><th><italic>Z</italic>-scores (SD)</th><th><italic>Z</italic>-scores (SD)</th><th>Mean score difference (95% CI)</th><th/></tr></thead><tbody><tr><td>Identification</td><td>Attention</td><td>Speed of performance log10 milliseconds</td><td>− 0.39 (0.48)</td><td>− 0.34 (0.81)</td><td>0.05 (− 0.80/0.91)</td><td>0.88</td></tr><tr><td>Detection</td><td>Psychomotor function</td><td>Speed of performance log10 milliseconds</td><td>− 0.65 (0.93)</td><td>− 0.72 (0.64)</td><td>− 0.07 (− 0.5/0.42)</td><td>0.75</td></tr><tr><td>One Card Learning</td><td>Visual learning</td><td>Accuracy of performance</td><td>− 0.66 (1.09)</td><td>− 0.62 (1.6)</td><td>0.03 (− 1.11/1.18)</td><td>0.94</td></tr><tr><td>One Back</td><td>Working memory</td><td>Speed of performance log10 milliseconds</td><td>− 0.01 (0.97)</td><td>− 2.13 (1.02)</td><td>− 2.11(− 2.7/− 1.4)</td><td>0.001</td></tr><tr><td>Groton Maze Chase</td><td>Visual-motor control</td><td>Moves per second</td><td>0.10 (1.02)</td><td>− 0.61 (0.9)</td><td>− 0.72 (− 1.20/− 0.20)</td><td>0.011</td></tr><tr><td>Groton Maze Learning</td><td>Executive function</td><td>Total number of errors</td><td>− 0.06 (0.98)</td><td>− 2.13 (1.2)</td><td>− 2.06 (− 2.90/− 1.22)</td><td>0.003</td></tr><tr><td>SET shifting</td><td>Executive function</td><td>Total number of errors</td><td>− 0.04 (0.96)</td><td>0.03 (1.02)</td><td>0.07 (− 0.64/0.80)</td><td>0.81</td></tr><tr><td>Global cognitive <italic>Z</italic>-score</td><td>Global cognition</td><td><italic>Z</italic>-score</td><td>− 0.19 (24)</td><td>− 0.58 (0.78)</td><td>− 0.24 (− 1.05/0.5)</td><td>0.24</td></tr></tbody></table><table-wrap-foot><p><italic>SD</italic>, standard deviation; <italic>CI</italic>, confidence interval; <italic>p</italic> value, two-tailed. Lower scores at Identification, Detection, One Back, Groton Maze Chase, Groton Maze Learning, SET shifting, Global cognitive score indicate better performance. Higher scores at the One Card Learning task indicate better performance</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Changes in cognitive function by study arm (NNRTI study)</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th>Baseline</th><th>6 months</th><th>Changes at 6 months from baseline</th><th>p value</th></tr><tr><th>Cognitive test</th><th>Cognitive domain</th><th>Outcome measure</th><th>Z-scores (SD)</th><th>Z-scores (SD)</th><th>Mean score difference (95% CI)</th><th/></tr></thead><tbody><tr><td>Identification</td><td>Attention</td><td>Speed of performance log10 milliseconds</td><td>− 0.39 (0.48)</td><td>− 0.34 (0.81)</td><td>0.05 (− 0.80/0.91)</td><td>0.88</td></tr><tr><td>Detection</td><td>Psychomotor function</td><td>Speed of performance log10 milliseconds</td><td>− 0.65 (0.93)</td><td>− 0.72 (0.64)</td><td>− 0.07 (− 0.5/0.42)</td><td>0.75</td></tr><tr><td>One Card Learning</td><td>Visual learning</td><td>Accuracy of performance</td><td>− 0.66 (1.09)</td><td>− 0.62 (1.6)</td><td>0.03 (− 1.11/1.18)</td><td>0.94</td></tr><tr><td>One Back</td><td>Working memory</td><td>Speed of performance log10 milliseconds</td><td>− 0.01 (0.97)</td><td>− 2.13 (1.02)</td><td>− 2.11(− 2.7/− 1.4)</td><td>0.001</td></tr><tr><td>Groton Maze Chase</td><td>Visual-motor control</td><td>Moves per second</td><td>0.10 (1.02)</td><td>− 0.61 (0.9)</td><td>− 0.72 (− 1.20/− 0.20)</td><td>0.011</td></tr><tr><td>Groton Maze Learning</td><td>Executive function</td><td>Total number of errors</td><td>− 0.06 (0.98)</td><td>− 2.13 (1.2)</td><td>− 2.06 (− 2.90/− 1.22)</td><td>0.003</td></tr><tr><td>SET shifting</td><td>Executive function</td><td>Total number of errors</td><td>− 0.04 (0.96)</td><td>0.03 (1.02)</td><td>0.07 (− 0.64/0.80)</td><td>0.81</td></tr><tr><td>Global cognitive Z-score</td><td>Global cognition</td><td>Z-score</td><td>− 0.19 (24)</td><td>− 0.58 (0.78)</td><td>− 0.24 (− 1.05/0.5)</td><td>0.24</td></tr></tbody></table></div>SD, standard deviation; CI, confidence interval; p value, two-tailed. Lower scores at Identification, Detection, One Back, Groton Maze Chase, Groton Maze Learning, SET shifting, Global cognitive score indicate better performance. Higher scores at the One Card Learning task indicate better performance</transformed-table></extracted-table><extracted-table><table-id>Tab3</table-id><table-label>Table 3</table-label><table-caption>Association between clinical data and behavioural results for the NNRTI study</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table 3</label><caption><p>Association between clinical data and behavioural results for the NNRTI study</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Mean values (SD)</th><th>SSRT (<italic>p</italic>)</th><th>RT (<italic>p</italic>)</th><th>Accuracy (<italic>p</italic>)</th></tr></thead><tbody><tr><td>Years with HIV</td><td>14.0 (5.2)</td><td>0.99</td><td>0.645</td><td>0.59</td></tr><tr><td>Years on efavirenz</td><td>4.8 (3.1)</td><td>0.02</td><td>0.18</td><td>0.20</td></tr><tr><td>CD4 count (cells/μL)</td><td>601.7 (168.7)</td><td>0.38</td><td>0.35</td><td>0.56</td></tr><tr><td>CD8 count (cells/μL)</td><td>551.6 (150.8)</td><td>0.89</td><td>0.35</td><td>0.56</td></tr><tr><td>CD4/CD8 ratio</td><td>1.1 (0.3)</td><td>0.51</td><td>0.35</td><td>0.69</td></tr></tbody></table><table-wrap-foot><p>Years with HIV and years on efavirenz are expressed in years, CD4 and CD8 count in (cells/μL). (<italic>p</italic>), <italic>p</italic> value, obtained using a repeated-measure ANOVA</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Association between clinical data and behavioural results for the NNRTI study</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>Mean values (SD)</th><th>SSRT (p)</th><th>RT (p)</th><th>Accuracy (p)</th></tr></thead><tbody><tr><td>Years with HIV</td><td>14.0 (5.2)</td><td>0.99</td><td>0.645</td><td>0.59</td></tr><tr><td>Years on efavirenz</td><td>4.8 (3.1)</td><td>0.02</td><td>0.18</td><td>0.20</td></tr><tr><td>CD4 count (cells/μL)</td><td>601.7 (168.7)</td><td>0.38</td><td>0.35</td><td>0.56</td></tr><tr><td>CD8 count (cells/μL)</td><td>551.6 (150.8)</td><td>0.89</td><td>0.35</td><td>0.56</td></tr><tr><td>CD4/CD8 ratio</td><td>1.1 (0.3)</td><td>0.51</td><td>0.35</td><td>0.69</td></tr></tbody></table></div>Years with HIV and years on efavirenz are expressed in years, CD4 and CD8 count in (cells/μL). (p), p value, obtained using a repeated-measure ANOVA</transformed-table></extracted-table></extracted-tables-set>